Biomarker driven therapies, also known as precision or personalized medicine, involve using specific biological markers to guide the treatment of cancer. These biomarkers can be genes, proteins, or other molecules that provide information about the cancer's characteristics. By targeting these biomarkers, therapies can be more effective and tailored to the individual's cancer profile.
